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Abstract
lntroduction: The aim of this study was to investigate the association between
serum level of arsenic
and bladder cancer in people with bladder cancer in Kerman province.
Materials and Methods: Our study was a cross-sectional study with control
group, which was performed
by simple non-random sampling on 40 pa"ents with bladder cancer in the
department of urology of
Kerman from farvardin 1394 for one year. The demographic data including
name, age, sex, smoking, and
opium consumption were asked by the researcher in the data collection
checklist. Blood samples were
taken for all patients without anticoagulant and then measured by atomic
absorption method. Then all
the data were entered into the spss software for analysis.
ResultsiThe mean serum level of 'arsenic in the case group was 12.2 t t.Oa yg /
group was 1.43 + 0.73, which was sta"s"cally significant (P = 0.001). i.
Conclusion: Our data showed that serum level of arsenic in patients with
bladder cancer (case group)
was higher than that of the control group, which was the result of previous
studies on the role of arsenic
carcinogens in urethral cells Bladder confirms. Also, other underlying variables
such as urbanization,
gender, smoking and opium in bladder cancer patients were not associated
with the concentration of
this element in serum between the two groups.
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